Skip Navigation

Corrigendum for Authors/Task Force Members et al., Eur Heart J 27 (16) 1979-2030.

European Heart Journal Advance Access originally published online on July 31, 2007
European Heart Journal 2007 28(16):2046; doi:10.1093/eurheartj/ehm315
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
28/16/2046    most recent
ehm315v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Fuster, V.
Right arrow Articles by Wann, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Fuster, V.
Right arrow Articles by Wann, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2007. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation–executive summary. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation)

Valentin Fuster, Lars E. Rydén, David S. Cannom, Harry J. Crijns, Anne B. Curtis, Kenneth A. Ellenbogen, Jonathan L. Halperin, Jean-Yves Le Heuzey, G. Neal Kay, James E. Lowe, S. Bertil Olsson, Eric N. Prystowsky, Juan Luis Tamargo and Samuel Wann

Corrigendum to: ‘ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation–executive summary. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation)’ [Eur Heart J 2006;27: 1979–2030]

The following corrections are needed to Table 18, page 2012:

  1. This table should be retitled to "Pharmacological treatment before cardioversion in patients with persistent AF: effects of various antiarrhythmic drugs on immediate recurrence, outcome of transthoracic direct-current shock, or both".
  2. Quinidine should be deleted from the table (Enhance conversion by DC shock and prevent IRAFa column).
  3. The authors prefer that the third column be transposed to the fifth column.
  4. The recommendation class for the treatments with known efficacy (row 1, column 3) is IIa rather than I.
These errors have been corrected in the current online version of the article.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
28/16/2046    most recent
ehm315v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Fuster, V.
Right arrow Articles by Wann, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Fuster, V.
Right arrow Articles by Wann, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?